The potential of AZGP1 as a soluble biomarker has also been reported in the serum of patients with gastrointestinal tract cancers [Huang et al. 2013] and colorectal cancer [Ji et al. 2013]. This evidence concerns the gene AZGP1 and colorectal cancer.